Antihistamines offer new hope for erythropoietic protoporphyria-related liver disease

Post author:admin
Post published:January 20, 2025
Post category:uncategorized

Chlorcyclizine shows promise in reducing protoporphyrin-IX accumulation and liver damage in erythropoietic protoporphyria, targeting histamine pathways.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Study: Hepatitis E virus may be both sexually transmitted and linked to male infertility

Stilla Technologies expands U.S. presence through strategic distribution relationship with Avantor and introduces advanced content offerings

Helpful Links

Subscribe To Us